4Friends3YTyler

Threshold Pharmcaceuticals

看多
4Friends3YTyler 已更新   
NASDAQ:THLD   None
THLD triggered my first level 1.29$ above the pennie mode. Main reason for it might be the release of phase III data from its clinical stage studies of Tarloxotinib. The data will be released somewhere in September. My next levels are 2.15$ and 2.75$.
評論:
THLD release candidate failed. They wanna concentrate on clinical studies.... Unexpected downmove. But there seem to be some buyers left. I watch this by now.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。